Insulet recalls 7M patch pumps due to leak risk

The Latest

• 

  Ōura files for IPO amid healthcare push

  The smart ring maker’s filing follows a recent $900 million fundraise and comes amid plans to develop more health features for the device.

  Digital Health

• 

  Medtronic to create European software hub in Ireland

  The investment in cardiac digital health will add 85 jobs initially, with more growth expected over the next three years.

  Cardiac

• 

  Intuitive readies 100 updates and improvements for da Vinci 5

  Some updates to Intuitive’s surgical robot aim to improve communication between remote and on-site physicians to expand education opportunities.

  Medical Devices

• 

  Sentante lands Europe’s CE mark for endovascular robot

  The Lithuania-based robotic surgery company is advancing a remote stroke system that was accepted into the FDA’s total product life cycle advisory program earlier this year.

  Medical Devices

• 

  Medtronic to buy SPR Therapeutics for about $650M

  Medtronic would gain a treatment for chronic pain management in its third major acquisition this year.

  M&A

• 

  Stryker’s chief accounting officer to retire

  William Berry Jr. will retire in September, with Corporate Controller Emily Baculik stepping into the role.

  Earnings

• 

  Guardant wins FDA approval for updated liquid biopsy

  The company could secure a higher price for the new test than for its older, narrower product, Wall Street analysts said.

  FDA

• 

  Medtronic data back renal denervation in the long term

  Analyses presented at EuroPCR assessed Medtronic’s Symplicity blood pressure procedure in patient groups with severe hypertension and who had prior cardiovascular events.

  Cardiac

• 

  Endologix buys clot removal system from Surmodics

  Endologix will market the system to vascular interventionists who use its other devices to treat peripheral artery disease and abdominal aortic aneurysms.

  M&A

• 

  Top medtech executive moves in 2026

  Integra LifeSciences has reappointed Stuart Essig as CEO, and Edwards Lifesciences and BD named new CFOs. Read MedTech Dive’s roundup for all the details.

  Updated May 20, 2026

  M&A

• 

  Boston Scientific posts positive data for coronary IVL catheter

  With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for patients with severely calcified coronary artery disease.

  Cardiac

• 

  Medtronic, BD name new leaders

  Kweli Thompson will be promoted to head of Medtronic’s neuroscience portfolio, and Peter Menziuso will join BD’s interventional business. 

  Medical Devices

• 

  Artivion closes Endospan buyout to acquire recently approved heart device

  Artivion is targeting a $150 million annual U.S. market for the Nexus Aortic Arch System.

  M&A

• 

  Boston Scientific buys $1.5B stake in TAVR developer MiRus

  The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional payments totaling $3 billion.

  M&A

• 

  Natera wins FDA approval for companion diagnostic

  The test will enable physicians to assess if post-surgery cancer patients need to receive treatment to minimize the risk of recurrence.

  FDA

• 

  Embecta closes Owen Mumford acquisition for up to $201M

  Embecta bought the company, which has an auto-injector platform, to expand outside of diabetes care.

  M&A

• 

  Dexcom to add 2 board directors with activist investor Elliott

  CEO Jake Leach also discussed the company’s plans for its G8 glucose sensor, dual-analyte sensing and Medicare coverage at an investor day.

  Diabetes

• 

  Carl Zeiss says restructuring could affect up to 1,000 jobs

  A weak investment climate in the Americas contributed to declines in the German company’s intraocular lens business in the first half of its fiscal year.

  Earnings

• 

  Labcorp expands Epic pact to make full test menu available on Aura

  The Labcorp agreement continues the expansion of Aura, which gives healthcare providers access to tests from companies including Quest Diagnostics.

  Diagnostics

• 

  Oracle adds Cleveland Clinic CEO to board of directors

  Dr. Tomislav Mihaljevic’s appointment comes months after Oracle named former Quest Diagnostics CEO Stephen Rusckowski to the board as the technology giant expands its reach in the healthcare sector.

• 

  FDA chief Marty Makary resigns from agency, ending tumultuous tenure

  Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.  

  FDA

• 

  4 medtech manufacturers recall kits over problem with Medline syringes

  AVID Medical, Aligned Medical Solutions, Medical Action Industries and American Contract Systems all sent notices to customers about convenience kits that contain recalled Medline angiographic syringes.

  Recalls

• 

  J&J launches improved Shockwave catheter

  The latest generation of the coronary intravascular lithotripsy device is designed to be more flexible to help physicians navigate tight arteries to break up calcified deposits and restore blood flow.

  Cardiac

• 

  Artera gets FDA clearance for AI breast cancer risk prediction tool

  The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.

  FDA

• 

  Stryker values Amplitude Vascular purchase at up to $835M

  The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, includes $435 million upfront and up to $400 million in milestone payments.

  M&A

More stories